Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients

Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients

Backgrounds and PurposeConcurrent non-alcoholic fatty liver disease (NAFLD) in chronic hepatitis B (CHB) patients is a frequent and increasingly concerning problem because of the NAFLD pandemic. Admittedly, NAFLD can progress to non-alcoholic steatohepatitis (NASH) and severe fibrosis. Direct eviden...

Full description

Bibliographic Details
Main Authors: Yan Huang, Qinyi Gan, Rongtao Lai, Weijing Wang, Simin Guo, Zike Sheng, Lu Chen, Qing Guo, Wei Cai, Hui Wang, Gangde Zhao, Zhujun Cao, Qing Xie
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
hepatitis B
non-alcoholic fatty liver disease (NAFLD)
non-alcoholic steatohepatitis (NASH)
liver biopsy
liver fibrosis
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2021.733348/full

Similar Items

Similar Items